(–)-Sitagliptin Carbamoyl Glucuronide – 500 µg

Brand:
Cayman
CAS:
940002-59-5
Storage:
-20
UN-No:
Non-Hazardous - /

(–)-Sitagliptin carbamoyl glucuronide is a minor phase II metabolite of the dipeptidyl peptidase 4 (DPP-4) inhibitor (–)-sitagliptin (Item No. 13252).{47124} (–)-Sitagliptin carbamoyl glucuronide is formed by N-carbamoyl glucuronidation and has been found in rat and dog plasma following administration of (–)-sitagliptin.  

 

Available on backorder

SKU: 26629 - 500 µg Category:

Description

A minor phase II metabolite of (–)-sitagliptin; formed by N-carbamoyl glucuronidation; has been found in rat and dog plasma


Formal name: 1-[N-[(1R)-3-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]carbamate] β-D-glucopyranuronic acid

Synonyms:  (R)-Sitagliptin Carbamoyl Glucuronide

Molecular weight: 627.5

CAS: 940002-59-5

Purity: ≥90%

Formulation: A solid


Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Toxicology|Drug Metabolism|Drug Metabolites